We Want to
Hear From You

Get in touch

Looking forward to hearing from you and learning more about how we can help.

Office Locations

Exiger Named in Fast Company’s 2024 List of Brands That Matter

The annual award recognizes brands that achieve cultural significance and deep customer connections. Exiger was included in the United States Brands category. This is the second consecutive year that Exiger has been recognized.

our blog

Perspectives

FOCI Concerns in software

JAWS - FOCI Concerns in Widely Deployed Accessibility Software

Measuring and Managing: How to Leverage C-SCRM in Procurement webinar on June 26 at 2 PM ET

Measuring and Managing: How to Leverage C-SCRM in Procurement

UFLPA Webinar

UFLPA at Three: A Customer-Exclusive Briefing on Enforcement, Compliance & What’s Next

Axios, Hope King, and Exiger CEO, Brandon Daniels in The View From The Top discussions.

A View from the Top

Axios Press Release - Perspectives

Building the Future: AI, Trade, and the New Rules of Power (Axios | Exiger Summit)

Critical Minerals Webinar - Perspectives

A Bitter Pill: America's Dangerous Dependence on China-Made Pharmaceuticals

Non-Security Metrics To Identify & Quantify Security Related Risk

Why Non-Security Metrics Matter in Cybersecurity Assessments

AI, Trade Shocks, and Ethical Supply Chains

AI, Trade Shocks, and Ethical Supply Chains

Watch the on-demand webinar from Exiger and Baker Tilly, A New Chapter for the DIB: Supply Chain Risk Oversight in the Trump Era

A New Chapter for the DIB: Supply Chain Risk Oversight in the Trump Era

Supplier Risk Management Magic Quadrant

Exiger Recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for Supplier Risk Management Solutions

Gartner Critical Capabilities

Exiger is Ranked 1st for the Supplier Risk Identification Use Case and Supply Ecosystem Risk Management Use Case in the Inaugural Gartner® Critical Capabilities for Supplier Risk Management Solutions

Critical Minerals Webinar - Perspectives

A Bitter Pill: America's Dangerous Dependence on China-Made Pharmaceuticals